As Lung Cancer Awareness Month comes to a close, Henry Ford Health is proud to announce it has received an anonymous gift of $10 million, which is poised to significantly advance lung cancer research at Henry Ford Cancer.
This transformative gift has enabled Henry Ford to establish a new lung cancer tissue biorepository, which is a facility that catalogs and stores biological samples for research. These samples – in this case, lung cancer tissue – are crucial for scientists who are studying the disease at a molecular level, which can lead to potential breakthroughs in the diagnosis and treatment of lung cancer for patients in Michigan and beyond.
This new lung cancer tissue biorepository strengthens Henry Ford’s position as a global leader in cancer research and mirrors the brain cancer tissue biorepository already in place at Henry Ford Cancer. Both facilities represent the institution's commitment to cutting-edge research and personalized medicine. The lung cancer biorepository will house tissue samples from a diverse patient population, providing a valuable resource for researchers.
This generous gift has also enabled the strategic expansion of Henry Ford’s specialized clinical trials program. These developments are an important part of the health system’s ability to drive innovation for the benefit of patients not only in Michigan, but also around the world.
The comprehensive lung cancer program at Henry Ford Health, renowned for its emphasis on early detection, patient support, advanced treatment options and translational research, continues to set benchmarks in medical excellence. With the support of this extraordinary gift, Henry Ford Health reaffirms its position at the forefront of lung cancer medicine and research, offering hope and new possibilities in the battle against the leading cause of cancer-related death in the U.S.